Home › Peripheral Arterial Disease › New Hampshire
Peripheral Arterial Disease clinical trials in New Hampshire
3 studies for Peripheral Arterial Disease are looking for participants at sites in New Hampshire.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Seacoast Kidney and Hypertension Specialists, Portsmouth
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Dartmouth-Hitchcock Medical Center, Lebanon
Recruiting
Ages 18 to 95 · All sexes · Updated Apr 16, 2026 · NCT05313165Improving Mobility After Revascularization in Peripheral Artery Disease
- Dartmouth Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 26, 2025 · NCT06686121From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.